"Everyone acquainted with the subject will recognize it as a conspicuous failure."
Henry Morton, president of the Stevens Institute of Technology ; Said in 1880 about the light bulb
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7960584 | Compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same This present invention relates to novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor (Vanilloid Receptor 1; VR1; TRPV1) antagonist; and a pharmaceutical composition containing the same. The present invention provides a... | 06/14/2011 |
| 7351738 | Substituted ureas and carbamates The invention provides compounds of formula I: useful in treating Alzheimer's disease and other similar diseases. These compounds include inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer... | 04/01/2008 |
| 7326746 | Curable electron donor compositions Electron donor compounds, suitable for use as adhesives or as components in adhesives, contain a carbon to carbon double bond attached to an aromatic ring and conjugated with the unsaturation in the aromatic ring. ... | 02/05/2008 |
| 6908957 | Curable electron donor compounds Electron donor compounds, suitable for use as adhesives or as components in adhesives, contain a carbon to carbon double bond attached to an aromatic ring and conjugated with the unsaturation in the aromatic ring. ... | 06/21/2005 |
| 6900213 | Bisaryl derivatives having FSH modulatory activity The invention relates to bisaryl derivatives of the formula I, wherein (R,R) is selected from (H,H), O, (H,CH3), (H,OH) and (H,CN); Ar is substituted phenyl and A is a group of formula II, III, IV ... | 05/31/2005 |
| 6872851 | Substituted cyclic compounds, preparation method and pharmaceutical compositions containing them The invention concerns compounds of formula (I): R—A—R′ wherein: A is as defined in the description; R represent, a group (V), wherein R′a and R″a are as defined in the description, or R forms with A a cyclic structure as defined in t... | 03/29/2005 |
| 6841701 | Inhibitors for the blood-clotting factor Xa The invention relates to derivatives of amidino-benzylamine, especially derivatives of 4-amidino-benzylamine, with two bonded amino acids. These derivatives represent a novel group of highly active and very selective F Xa-inhibitors for treating cardiovascular disea... | 01/11/2005 |
| 6777561 | Compounds Compounds of general formula I are disclosed and claimed in the present application, as well as their pharmaceutically acceptable salts, pharmaceutical compositions comprising the novel compounds and their use in therapy... | 08/17/2004 |
| 6730784 | Urea derivatives useful as synthetic intermediates Objects of the present invention are to create compounds having urea structure as basic structure and having a sulfur atom and an amide bond in side chains and to find pharmacological effects thereof, particularly TNF-α production inhibitory effects. The pre... | 05/04/2004 |
| 6723875 | Process to prepare alkyl-ureas from O,S-dimethyl dithiocarbonate The present invention relates to the preparation of alkyl-ureas, starting from O,S-dimethyl dithiocarbonate, which provides the following steps: A) causing the O,S-dimethyl dithiocarbonate to react with a primary amine of general formula R1NH2... | 04/20/2004 |
| 6683200 | N-substituted-N'-substituted urea derivatives and pharmaceutical compositions containing the derivatives N-Substituted-N'-substituted urea derivatives represented by the following formula, analogs thereof or pharmaceutically acceptable salts thereof are herein provided. These compounds show a TNF- production inhibitory activity. ##STR1##... | 01/27/2004 |
| 6635650 | Substituted dimeric compounds The invention relates to compounds of formula (I): wherein: A represents NR1 C(Q)R2, C(Q)NR2 R3 or NR1 C(Q)NR2 R3, B represents NR1 C(Q)R2, C(Q)NR2... | 10/21/2003 |
| 6620961 | Biarylalkylenecarbamic acid derivatives and bacteriocides for agricultural and horticultural use Biarylalkylenecarbamic acid derivative represented by general formula (I): ##STR1## [wherein Q is a phenyl group which may be substituted or the like, X is a halogen atom, a (C1 -C6) alkyl group or the like, n is 0 or an integer of f... | 09/16/2003 |
| 6528543 | Urea derivatives Glucokinase activating compounds of the formula ##STR1## wherein R1 and R2 are independently hydrogen, halo, amino, nitro, cyano, sulfonamido, lower alkyl, perfluoro-lower alkyl, lower alkyl thio, perfluoro-lower alkyl thio, lower al... | 03/04/2003 |
| 6423870 | Tricyclic compounds, preparation method and pharmaceutical compositions containing same The invention concerns compounds of formula (I) in which: A forms a tricyclic system of formula A1, A2, A3 or A4 ; R1 represents a hydrogen atom, an alkyl, hydroxy, alkoxy or oxo group; (R2... | 07/23/2002 |
| 6329529 | Nitrogen-based halogenating agents and process for preparing halogen-containing compounds Disclosed are a fluorinating agent represented by the general formula (1): ##STR1## wherein R1 to R4 are a substituted or unsubstituted, saturated or unsaturated alkyl group or a substituted or unsubstituted aryl group, and can be th... | 12/11/2001 |
| 6319930 | Substituted dimeric compounds The invention relates to compounds of formula (I): A--G1 --Cy--G2 --Cy--G3 --B (I) wherein: A represents NR1 C(Q)R2, C(Q)NR2 R3 or NR1 C(Q)NR2 R3, B repre... | 11/20/2001 |
| 6313071 | Phenylacetylene derivatives and agricultural/horticultural fungicides A phenylacetylene derivative represented by the formula [I]: ##STR1## {wherein X is a halogen atom, a C1 -C6 alkyl group, a C2 -C6 alkoxy group, a C2 -C6 haloalkyl group, etc., n is 0 or an... | 11/06/2001 |
| 6310074 | Substituted dimeric compounds The invention relates to compound of formula (I): A--G1 --Cy--G2 --Cy'--G3 --B (I) wherein: A represents a grouping NR1 C(Q)R2, C(Q)NR2 R3 or NR1 C(Q)NR2 R3 | 10/30/2001 |
| 6235789 | Benzocycloalkene compounds, their production and use A compound of the formula ##STR1## wherein R1 and R2 are H, a hydrocarbon group or a heterocyclic group, or R1 and R2 are combinedly a spiro ring; R3 is a hydrocarbon group, a substituted amino group,... | 05/22/2001 |
| 6184410 | Carbodiimides based on 1,3-bis(1-methyl-1-isocyanatoethyl)benzene Carbodiimides based on 1,3-bis(1-methyl-1-isocyanatoethyl)benzene contain from 12 to 40% by weight of ethylene oxide units [--CH2 --CH2 --O--], based on the weight of the carbodiimides.... | 02/06/2001 |
| 6152968 | Water-soluble Quinacridones The use of water-soluble quinacridones of the formula I ##STR1## where M.sym. is a lithium, sodium, potassium or ammonium cation, R1, R2, R3 and R4 independently are hydrogen, C1 -C8 | 11/28/2000 |
| 6140531 | Method of preparing N-1-alkenyl carbonylamino compounds Describes a method of producing N-1-alkenyl carbonylamino compounds represented by the following general formula I, ##STR1## wherein R1 is the residue of an active hydrogen functional material, n is a number from 1 to a number equal to the... | 10/31/2000 |
| 6140368 | Naphthols useful in antiviral methods The present invention relates to a novel class of compounds that are potent inhibitors of HIV reverse transcriptase and HIV integrase. In addition to being multienzyme inhibitors, the inventive compounds of the present invention are remarkable in at least... | 10/31/2000 |
| 6127414 | NPY antagonists There is provided pharmaceutically useful compounds of formula I, ##STR1## wherein Ar1, R1, R2, R3, R4, R5 and R6 have meanings given in the description, which are useful as anta... | 10/03/2000 |
| 6114390 | Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them NPY-antagonistic compounds of the formula ##STR1## Exemplary are: (A) (R)-N-[[4-(Aminocarbonylaminomethyl)phenyl]methyl]-N.sup.2 -bis(4-hydroxyphenyl)acetyl]-argininamide-trifluoracetate; (B) (R)-N-[[4-(Aminocarbonylaminomethyl)phenyl]methyl]-N.sup.2... | 09/05/2000 |
| 6080874 | Synthesis and isolation of N-(aryl or heteroaryl)-alkyl-N-hydroxyurea The present invention provides a simple, 1-step process for preparing a N-(aryl or heteroaryl)-hydroxyurea comprising reacting the corresponding alcohol, ester or ether with hydroxyurea and acid. This reaction is particularly useful for preparing a benzo[... | 06/27/2000 |
| 6022899 | Substituted benzyloxy-carbonylguanidines, a process for their preparation, their use as a medicament or diagnostic, and a medicament containing them There are described compounds of the formula I ##STR1## in which the substituents R(1) to R(7) and X have the meanings shown in the claims, and their pharmaceutically tolerable salts. These are effective inhibitors of the cellular sodium proton antip... | 02/08/2000 |
| 5962530 | Amino acid derivatives, medicaments containing said compounds and methods of producing them The invention relates to new amino acid derivatives of general formula ##STR1## wherein R, U, V, Y, n, m and R1 to R3 are defined as in claim 1, their tautomers, diastereomers, enantiomers, mixtures thereof and salts thereof, pa... | 10/05/1999 |
| 5932595 | Matrix metalloprotease inhibitors The present invention relates to compounds of Formula I: ##STR1## that are matrix metalloprotease inhibitors, pharmaceutical compositions containing them, methods for their use and methods of preparing these compounds.... | 08/03/1999 |
| 5922771 | Benzocycloalkene compounds, their production and use A compound of the formula ##STR1## wherein R1 and R2 independently represent H or an optionally substituted hydrocarbon group; R3 represents an optionally substituted hydrocarbon group; R4 represents H or a... | 07/13/1999 |
| 5892100 | Method for producing N-acyl carbamate The present invention provides a method for producing N-acyl carbamate in high yield. The method of the present invention comprises the step of reacting an unsaturated acid halide with a carbamate in the presence of a hindered amine. Another method of the... | 04/06/1999 |
| 5849732 | Phenol compound having antioxidative activity and the process for preparing the same Disclosed are a phenol compound represented by the formula (1): ##STR1## wherein R0 represents H, alkyl or alkyloxy; R1 represents alkyl; R2 represents alkyl or alkyloxy; OR3 represents OH; R4 re... | 12/15/1998 |
| 5811456 | Monoamine oxidase B inhibitors, processes for their preparation and use thereof Novel monoamine oxidase B inhibitors of formula (I), wherein R1 .dbd.H, an optionally substituted benzyloxy or phenylethoxy group; p=0-3; R3 .dbd.H, a CN, OH, CCH group, a C1 -C3 alkoxy-carbonyl group, or a C | 09/22/1998 |
| 5807875 | Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them Amino acid derivatives, suitable for the treatment of obesity. The following compound is exemplary of the class: (R,S)-N2 -(diphenylacetyl)-N-(4-hydroxyphenyl)methyl!-N5 -(1H-imidazol-2-yl)-ornithinamide.... | 09/15/1998 |
| 5780512 | Alkylated (hetero) cyclic compounds The invention relates to a compounds selected from these of formula (I): ##STR1## in which: R1, R2, R3 and A are as defined in the description, and a medicinal product containing the same useful for treating a melaton... | 07/14/1998 |
| 5760071 | Aryl(alkyl)propylamides The invention relates to a compound selected from those of formula (I): ##STR1## in which A, R1, R'1, R2, R3 and n are as defined in the description, and medicinal product containing the same useful for tre... | 06/02/1998 |
| 5714633 | Process for the preparation of arylalkynyl-N-hydroxyurea derivatives having lipoxygenase inhibitory activity The present invention provides a process for the preparation of a compound of formula ##STR1## wherein R is a straight or branched alkyl group of from one to twelve carbon atoms; M represents hydrogen or a pharmaceutically acceptable cation; and... | 02/03/1998 |
| 5712312 | Tricyclic amides The invention relates to a compound selected from these of formula (I): ##STR1## in which R7, R8, Y, n and A are as defined in the description, and medicinal product containing the same useful for treating a disorder of the mela... | 01/27/1998 |
| 5703076 | Retroviral protease inhibitors Urea-containing hydroxyethylamine compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.... | 12/30/1997 |